Efforts to enhance AAV8-mediated gene therapy of Pompe disease

被引：0
|
作者：
Zieler, R. [1 ]
Bercury, S. [1 ]
Zhu, Y. [1 ]
Foley, J. [1 ]
Glimlaw, N. [1 ]
Koeberl, D. [2 ]
Scheule, R. [1 ]
Cheng, S. [1 ]
机构：
[1] Genzyme Corp, Framingham, MA 01701 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC USA
来源：
NEUROMUSCULAR DISORDERS | 2007年 / 17卷 / 9-10期
关键词：
D O I：
10.1016/j.nmd.2007.06.427
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：890 / 890
页数：1
相关论文
共 50 条
  • [31] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 309 - 309
  • [32] Lentivirus mediated gene therapy for murine model of Pompe disease
    Kyosen, S. O.
    Iizuka, S.
    Morita, A.
    Kimura, T.
    Kobayashi, H.
    Eto, Y.
    Ida, H.
    Ohashi, T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 99 - 99
  • [33] AAV8 mediated gene therapy for corneal cystinosis
    Duy Nguyen
    Du, Hongjun
    Bedell, Matthew
    Grob, Seanna
    Luo, Jing
    Quach, John
    Shaw, Peter
    Cherqui, Stephanie
    Zhang, Kang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] AN OPEN LABEL PHASE 1/2 CLINICAL TRIAL FOR AAV8-MEDIATED LIVER-DIRECTED GENE THERAPY IN ADULTS WITH GLYCOGEN STORAGE DISEASE TYPE IA
    Weinstein, David A.
    Ahmad, Ayesha
    Poma, Allen
    Crombez, Eric
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 333 - 333
  • [35] Treatment with bone maturation and average lifespan of HPP model mice by AAV8-mediated neonatal gene therapy via single muscle injection
    Matsumoto, Tae
    Miyake, Koichi
    Miyake, Noriko
    Iijima, Osamu
    Adachi, Kumi
    Narisawa, Sonoko
    Millan, Jose Luis
    Orimo, Hideo
    Shimada, Takashi
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 22 : 330 - 337
  • [36] AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease
    McEachern, Kerry Anne
    Nietupski, Jennifer B.
    Chuang, Wei-Lien
    Armentano, Donna
    Johnson, Jennifer
    Hutto, Elizabeth
    Grabowski, Gregory A.
    Cheng, Seng H.
    Marshall, John
    JOURNAL OF GENE MEDICINE, 2006, 8 (06): : 719 - 729
  • [37] Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following AAV Gene Therapy
    McCall, Angela L.
    Stankov, Sylvia G.
    Falk, Darin J.
    Byrne, Barry
    MOLECULAR THERAPY, 2017, 25 (05) : 100 - 100
  • [38] Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease (vol 2, 15002, 2015)
    Wang, Gensheng
    Young, Sarah P.
    Bali, Deeksha
    Hutt, Julie
    Li, Songtao
    Benson, Janet
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2015, 2
  • [39] Visualization of spinal afferent innervation in the mouse colon by AAV8-mediated GFP expression
    Schuster, D. J.
    Dykstra, J. A.
    Riedl, M. S.
    Kitto, K. F.
    Honda, C. N.
    McIvor, R. S.
    Fairbanks, C. A.
    Vulchanova, L.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 (02): : E89 - E100
  • [40] Pompe disease gene therapy
    Byrne, Barry J.
    Falk, Darin J.
    Pacak, Christina A.
    Nayak, Sushrusha
    Herzog, Roland W.
    Elder, Melissa E.
    Collins, Shelley W.
    Conlon, Thomas J.
    Clement, Nathalie
    Cleaver, Brian D.
    Cloutier, Denise A.
    Porvasnik, Stacy L.
    Islam, Saleem
    Elmallah, Mai K.
    Martin, Anatole
    Smith, Barbara K.
    Fuller, David D.
    Lawson, Lee Ann
    Mah, Cathryn S.
    HUMAN MOLECULAR GENETICS, 2011, 20 : R61 - R68
12345